Costs of Care and Adherence to Treatment for Cystic Fibrosis

Completed

• Conditions: Cystic Fibrosis

• Registration Number: NCT02832479
• Lead Sponsor: Hospices Civils de Lyon

Brief Summary

Evolution of medical care for patients with cystic fibrosis appeared in recent years: prolongation of life expectancy with consequently increased comorbidities and the use of lung transplantation, systematic neonatal screening of new born since 2002, prescription of expensive new molecules or new presentation. This evolution justifies to realize an update of statistics of costs of care and to assess adherence to treatment

Detailed Description

Not available

Study Timeline

• Study Start: 2014-10
• Primary Completion: 2016-02
• Study Completion: 2016-02
• Status Verified: 2016-06
• Study First Submitted: 2016-06-21
• Study First Submitted QC: 2016-07-11
• Study First Posted: 2016-07-14
• Last Update Submitted: 2016-08-09
• Last Update Posted: 2016-08-10

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 500

Inclusion Criteria

• Patients with cystic fibrosis,
• Followed by one of the cystic fibrosis center of the Rhône-Alpes region (pediatric and adult of Lyon and Grenoble)
• Affiliated to the general scheme of health insurance,
• And domiciled in the Rhône-Alpes region.

Exclusion Criteria

• Transplanted patients

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
treatment cost	12 months

Secondary Outcome Measures

Name	Time	Method
adherence rate for chronic treatment	12 months

Trial Locations

Locations (1)

Hospices civils de Lyon, centre hospitalier lyon Sud; 🇫🇷 Pierre Benite, France